|

Hesperidin RCT in MS

RECRUITINGN/ASponsored by Swansea University
Actively Recruiting
PhaseN/A
SponsorSwansea University
Started2026-01-07
Est. completion2027-01-18
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07452562

Summary

This study is a randomised, double-blind, placebo-controlled trial investigating the effects of Hesperidin supplementation on cognitive function, fatigue, and stress. Participants will be randomly assigned to receive either 500mg of Hesperidin or a matching placebo daily for 12 weeks. The primary outcome is fatigue, with secondary outcomes including cognitive performance and mood. The trial seeks to determine if this dietary intervention offers symptom-alleviating benefits.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Diagnosis of Multiple Sclerosis, Aged 18 years or older.

Exclusion Criteria:

* Known food allergies, intolerances, or significant gastrointestinal (GI) problems, Participants under the age of 18 years.

Conditions1

Multiple Sclerosis

Browse More Trials

Multiple Sclerosis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.